Concepedia

Hikaru Mitori

HM

Statistics

Publications

5

Citations

270

H-Index

5

Active since

2014

Affiliations

Astellas Pharma (Japan)(Current)

Hikaru Mitori is an author at Astellas Pharma (Japan) specializing in medicine, renal pathophysiology, and nephrology.

Publications per year

2014–2019

5

Publications

5

Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats

Yuka Hayashizaki-Someya, Eiji Kurosaki, Toshiyuki Takasu et al. · European Journal of Pharmacology · 2015 · 108 citations

, , +15

Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats

Masayuki Kanki, Akira Moriguchi, Daisuke Sasaki et al. · Toxicology · 2014 · 80 citations

, , +8

ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against <i>Aspergillus</i> Species through a Specific Transporter

Ikuko Nakamura, Keisuke Ohsumi, Shinobu Takeda et al. · Antimicrobial Agents and Chemotherapy · 2019 · 44 citations · Full text

, , +17

Antiproteinuric effect of pirfenidone in a rat model of anti-glomerular basement membrane glomerulonephritis

Koji Takakura, Kazuhiko Mizukami, Hikaru Mitori et al. · European Journal of Pharmacology · 2014 · 19 citations

, , +11

Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models

Yusuke Wada, Masaki Abe, Hiroshi Moritani et al. · Experimental Biology and Medicine · 2016 · 19 citations · Full text

, , +17

1–5 of 5